
Hanna Wacker
Associate, Capital Markets
Bio
Hanna Wacker focuses her practice on capital markets transactions as well as general securities-related matters.
Ms. Wacker’s experience at Skadden includes advising, among others:
Capital Markets (Equity)
- Euronext Brussels and Euronext Amsterdam-listed ONWARD Medical, a leading developer of spinal cord injury therapies, in:
- a €50 million cash capital increase and cornerstone investment by Ottobock SE & Co. KGaA
- a €52.5 million debt financing from U.S. lender Runway Growth Finance
- Jefferies and BofA Securities as joint global coordinators and joint bookrunners in connection with capital increases of Zur Rose Group AG
Capital Markets (Equity-Linked/Debt)
- ONWARD Medical in connection with a loan agreement
Mergers and Acquisitions
- the management and supervisory boards of Fresenius in the company’s exit from the Austrian and international businesses of VAMED AG
- Armira and Boxine in Boxine’s €1 billion business combination with 468 SPAC I SE, one of the first de-SPAC transactions in the market involving a German-listed blanc cheque company
- SIGNA Sports United GmbH in connection with its US$3.3 billion initial public offering on the New York Stock Exchange as a result of its de-SPAC merger with Yucaipa Acquisition Corporation. The merger also included the acquisition of WiggleCRC Group
Prior to joining Skadden’s Frankfurt office, Ms. Wacker worked as a research assistant and completed a legal clerkship in New York.
Credentials
Education
- Second State Exam, Higher Regional Court of Frankfurt am Main, 2024
- First State Exam, University of Dusseldorf, 2021
Admissions
- Frankfurt am Main
Languages
- English
- German
Hanna Wacker
Associate, Capital Markets
hanna.wacker@skadden.com